RxNorm Semantic Concepts Index - 193
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "193".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 193 | acetylcarnitine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1930002 | Hyoscine hydrobromide trihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1930002 | Hyoscine hydrobromide trihydrate | Designated preferred name (PT) | NO | |
RxCUI: 1930002 | Hyoscine hydrobromide trihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1930192 | Aluminum sulfate hydrate | British preferred term (PTGB) | NO | |
RxCUI: 1930192 | Aluminum sulfate hydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1930192 | Aluminum sulfate hydrate | Designated preferred name (PT) | NO | |
RxCUI: 19307 | Bile-salt sulfotransferase | Designated preferred name (PT) | NO | |
RxCUI: 19307 | Bile-salt sulfotransferase | Full form of descriptor (FN) | NO | |
RxCUI: 19307 | Bile-salt sulfotransferase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 19316 | Bilirubin monoglucuronide transglucuronidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 19316 | Bilirubin monoglucuronide transglucuronidase | Designated preferred name (PT) | NO | |
RxCUI: 19316 | Bilirubin monoglucuronide transglucuronidase | Full form of descriptor (FN) | NO | |
RxCUI: 19317 | Bilirubin oxidase | Designated preferred name (PT) | NO | |
RxCUI: 19317 | Bilirubin oxidase | Full form of descriptor (FN) | NO | |
RxCUI: 193198 | Ribosomal ribonucleic acid (guanine-N^1^)-methyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 193198 | Ribosomal ribonucleic acid (guanine-N^1^)-methyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 193198 | Ribosomal ribonucleic acid (guanine-N^1^)-methyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 19324 | Biliverdin reductase | Designated preferred name (PT) | NO | |
RxCUI: 19324 | Biliverdin reductase | Full form of descriptor (FN) | NO | |
RxCUI: 1932493 | Argatroban monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 1932493 | Argatroban monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 19338 | bioallethrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 19338 | bioallethrin | Designated preferred name (PT) | NO | |
RxCUI: 19338 | bioallethrin | Full form of descriptor (FN) | NO | |
RxCUI: 19342 | Biochanin A | Designated preferred name (PT) | NO | |
RxCUI: 19342 | Biochanin A | Full form of descriptor (FN) | NO | |
RxCUI: 1934270 | Sodium glycerophosphate pentahydrate | Designated preferred name (PT) | NO | |
RxCUI: 1934270 | Sodium glycerophosphate pentahydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1934698 | Carbidopa monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 1934698 | Carbidopa monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1934790 | Doripenem monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 1934790 | Doripenem monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1935033 | Levofloxacin hemihydrate | Designated preferred name (PT) | NO | |
RxCUI: 1935033 | Levofloxacin hemihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1935141 | Lysine glutamate | Designated preferred name (PT) | NO | |
RxCUI: 1935141 | Lysine glutamate | Full form of descriptor (FN) | NO | |
RxCUI: 1935232 | Frovatriptan succinate monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 1935232 | Frovatriptan succinate monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1935236 | Pramipexole dihydrochloride monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 1935236 | Pramipexole dihydrochloride monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1935590 | Sodium nitroprusside dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 1935590 | Sodium nitroprusside dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 19357 | Biotin carboxylase | Designated preferred name (PT) | NO | |
RxCUI: 19357 | Biotin carboxylase | Full form of descriptor (FN) | NO | |
RxCUI: 19362 | Biotin synthetase | Designated preferred name (PT) | NO | |
RxCUI: 19362 | Biotin synthetase | Full form of descriptor (FN) | NO | |
RxCUI: 19362 | Biotin synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 19363 | Biotin-[acetyl-CoA carboxylase]synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 19363 | Biotin-[acetyl-CoA carboxylase]synthetase | Designated preferred name (PT) | NO | |
RxCUI: 19363 | Biotin-[acetyl-CoA carboxylase]synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 19363 | Biotin-[acetyl-CoA carboxylase]synthetase | Full form of descriptor (FN) | NO | |
RxCUI: 19364 | Biotin-[methylmalonyl-CoA-carboxyltransferase] synthetase | Designated preferred name (PT) | NO | |
RxCUI: 19364 | Biotin-[methylmalonyl-CoA-carboxyltransferase] synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 19364 | Biotin-[methylmalonyl-CoA-carboxyltransferase] synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 19364 | Biotin-[methylmalonyl-CoA-carboxyltransferase] synthetase | Full form of descriptor (FN) | NO | |
RxCUI: 19369 | Biotinidase | Designated preferred name (PT) | NO | |
RxCUI: 19369 | Biotinidase | Full form of descriptor (FN) | NO | |
RxCUI: 19377 | biperiden lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 19377 | biperiden lactate | Designated preferred name (PT) | NO | |
RxCUI: 19377 | biperiden lactate | Full form of descriptor (FN) | NO | |
RxCUI: 1938 | Calmodulin | Designated preferred name (PT) | NO | |
RxCUI: 1938 | Calmodulin | Full form of descriptor (FN) | NO | |
RxCUI: 1939294 | belimumab 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1939295 | belimumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1939296 | belimumab 200 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1939296 | belimumab 200 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939296 | belimumab 200 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939297 | belimumab 200 MG/ML [Benlysta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1939298 | belimumab Auto-Injector [Benlysta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1939299 | Benlysta 200 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1939299 | Benlysta 200 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939299 | Benlysta 200 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939299 | Benlysta 200 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939300 | belimumab 200 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1939301 | belimumab 200 MG/ML Auto-Injector [Benlysta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1939301 | belimumab 200 MG/ML Auto-Injector [Benlysta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1939305 | dexrazoxane 500 MG [Totect] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1939306 | dexrazoxane Injection [Totect] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1939307 | Totect Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1939308 | Totect 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1939308 | Totect 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939308 | Totect 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939310 | oligopeptide-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1939322 | milrinone lactate 5 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1939322 | milrinone lactate 5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939322 | milrinone lactate 5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939323 | voxilaprevir | Full form of descriptor (FN) | YES | |
RxCUI: 1939323 | voxilaprevir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1939323 | voxilaprevir | Designated preferred name (PT) | YES | |
RxCUI: 1939323 | voxilaprevir | Full form of descriptor (FN) | YES | |
RxCUI: 1939323 | voxilaprevir | Designated preferred name (PT) | YES | |
RxCUI: 1939324 | voxilaprevir 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1939325 | sofosbuvir / velpatasvir / voxilaprevir Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1939325 | sofosbuvir / velpatasvir / voxilaprevir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1939325 | sofosbuvir / velpatasvir / voxilaprevir Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1939326 | sofosbuvir / velpatasvir / voxilaprevir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1939327 | sofosbuvir / velpatasvir / voxilaprevir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1939328 | sofosbuvir / velpatasvir / voxilaprevir | Full form of descriptor (FN) | YES | |
RxCUI: 1939328 | sofosbuvir / velpatasvir / voxilaprevir | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1939328 | sofosbuvir / velpatasvir / voxilaprevir | Designated preferred name (PT) | YES | |
RxCUI: 1939329 | sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1939329 | sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939329 | sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1939329 | sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1939330 | Vosevi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1939331 | sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG [Vosevi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1939332 | sofosbuvir / velpatasvir / voxilaprevir Oral Tablet [Vosevi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1939333 | Vosevi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1939334 | Vosevi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1939335 | Vosevi 400 MG / 100 MG / 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1939335 | Vosevi 400 MG / 100 MG / 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939335 | Vosevi 400 MG / 100 MG / 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939335 | Vosevi 400 MG / 100 MG / 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939336 | Lidozen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1939337 | lidocaine 0.04 MG/MG / menthol 0.01 MG/MG [Lidozen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1939338 | lidocaine / menthol Topical Gel [Lidozen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1939339 | Lidozen Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1939340 | LidozenGel 4 % / 1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1939340 | LidozenGel 4 % / 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939340 | LidozenGel 4 % / 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939340 | LidozenGel 4 % / 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939345 | belimumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1939346 | belimumab 200 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1939346 | belimumab 200 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939346 | belimumab 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939347 | belimumab Prefilled Syringe [Benlysta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1939348 | Benlysta 200 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1939348 | Benlysta 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939348 | Benlysta 200 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939348 | Benlysta 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1939349 | belimumab 200 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1939350 | belimumab 200 MG/ML Prefilled Syringe [Benlysta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1939350 | belimumab 200 MG/ML Prefilled Syringe [Benlysta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1939352 | triprolidine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1939353 | triprolidine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1939354 | triprolidine HCl 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1939354 | triprolidine HCl 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1939371 | Hexamidine isethionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1939371 | Hexamidine isethionate | Designated preferred name (PT) | YES | |
RxCUI: 1939371 | Hexamidine isethionate | Full form of descriptor (FN) | YES | |
RxCUI: 1939372 | hymetellose (50 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1939373 | dexrazoxane hydrochloride 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1939374 | dexrazoxane hydrochloride 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1939374 | dexrazoxane hydrochloride 500 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1939375 | Cardioxane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1939376 | dexrazoxane hydrochloride 500 MG [Cardioxane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1939377 | dexrazoxane Injection [Cardioxane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1939378 | Cardioxane Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1939379 | CARDIOXANE 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1939379 | CARDIOXANE 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1939379 | CARDIOXANE 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1939382 | acetaminophen 32 MG / dextromethorphan hydrobromide 1 MG / phenylephrine hydrochloride 0.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1939382 | acetaminophen 32 MG / dextromethorphan hydrobromide 1 MG / phenylephrine hydrochloride 0.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1939382 | acetaminophen 32 MG / dextromethorphan hydrobromide 1 MG / phenylephrine hydrochloride 0.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1939382 | acetaminophen 32 MG / dextromethorphan hydrobromide 1 MG / phenylephrine hydrochloride 0.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1939383 | isocetyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1939613 | Polmacoxib | Designated preferred name (PT) | NO | |
RxCUI: 1939613 | Polmacoxib | Full form of descriptor (FN) | NO | |
RxCUI: 1939673 | Razupenem | Designated preferred name (PT) | NO | |
RxCUI: 1939673 | Razupenem | Full form of descriptor (FN) | NO | |
RxCUI: 19399 | Bis(2-ethylhexyl)phthalate esterase | Designated preferred name (PT) | NO | |
RxCUI: 19399 | Bis(2-ethylhexyl)phthalate esterase | Full form of descriptor (FN) | NO |